McKesson Corporation
HealthcareNYSE:MCK · New York Stock Exchange
+$1.68 today
Vol 0.26M · Avg 1.02M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-219.2%
avg 1903.1%
ROIC
31.5%
avg 16.7%
ROA
5.8%
avg 2.7%
Analysis
ROIC is currently the strongest return metric at 31.5% versus its period average of 16.7%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Brian S. Tyler | Chief Executive Officer & Director | $5.66M | — | 59 | $22,845.00 | 0.02% |
Martin Koffel | Executive Officer | $2.68M | — | 87 | — | — |
Kenny K. Cheung | Executive Vice President & Chief Financial Officer | $2.68M | — | 44 | $0.00 | <0.01% |
Britt J. Vitalone | Executive Officer | $2.68M | — | 57 | $22,534.38 | 0.02% |
Michele Lau | Executive Vice President & Chief Legal Officer | $2.23M | — | 50 | $3,247.00 | <0.01% |
LeAnn Smith | Executive Vice President & Chief Human Resources Officer | $1.52M | — | 51 | $4,798.00 | <0.01% |
Thomas L. Rodgers | Executive Vice President and Chief Strategy & Business Development Officer | $1.46M | — | 54 | $2,268.00 | <0.01% |
Saralisa C. Brau | Corporate Secretary | — | — | — | — | — |
Crystal Lennartz | President of Health Mart | — | — | — | — | — |
Jeni Dominguez | Head of Investor Relations | — | — | — | — | — |
Joan Eliasek | President of North American Pharmaceutical Distribution | — | — | — | — | — |
Kirk Kaminsky | Executive Vice President & Group President of North American Pharmaceutical Services | — | — | — | — | — |
Napoleon Rutledge Jr. | Senior Vice President, Controller & Chief Accounting Officer | — | — | 53 | $632.00 | <0.01% |
Todd Kleinow | VP of Strategic Distribution & Operations | — | — | — | — | — |
Paul A. Smith | Senior Vice President of Taxes | — | — | — | $4,798.00 | <0.01% |
Francisco Fraga | Executive Vice President, Chief Information Officer & Chief Technology Officer | — | — | 53 | $6,264.42 | <0.01% |
Kevin Kettler | Executive VP & President of Prescription Technology Solutions | — | — | — | $301.00 | <0.01% |
Kevin W. Emerson | Senior Vice President of Finance Operations | — | — | 53 | $301.00 | <0.01% |
Yiyi Frechette | Director of Investor Relations | — | — | — | — | — |
Stanton McComb | President of Medical-Surgical | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
18
$45.07M
Net Sentiment
$45.07M
Net selling
Most Active
TYLER BRIAN S.
4 transactions
1–10 of 18
Analysis
Insiders reported 0 buys worth $0.00 and 18 sells worth $45.07M over the last 12 months. That adds up to net selling of $45.07M. TYLER BRIAN S. was the most active insider with 4 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +20.2% | +15.0% (15yr)1 analysts |
| Revenue | N/A | N/A | +15.9% | +7.9% (15yr)7 analysts |
| Net Income | N/A | N/A | +19.1% | +10.2% (15yr)7 analysts |
| EBIT | N/A | N/A | +16.7% | +5.0% (15yr)7 analysts |
Analysis
Recent growth has been strongest in EPS at +20.2% over three years. Forward estimates point to EPS at +15.0% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
CVS Health Corporation
NYSE:CVS
$129.99B
Stryker Corporation
NYSE:SYK
$119.99B
Bristol-Myers Squibb Company
NYSE:BMY
$116.51B
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
$112.63B
GSK plc
NYSE:GSK
$106.57B
Sanofi
NASDAQ:SNY
$106.49B
Medtronic plc
NYSE:MDT
$103.02B
HCA Healthcare, Inc.
NYSE:HCA
$85.82B
Cencora, Inc.
NYSE:COR
$54.79B
Cardinal Health, Inc.
NYSE:CAH
$52.49B
Who manages MCK?
McKesson Corporation (MCK) lists 20 active executives. The top listed executive is Thomas L. Rodgers, Executive Vice President and Chief Strategy & Business Development Officer.
Are MCK insiders buying or selling?
Recent insider activity shows net selling of $113.04M.
Explore More
Continue the stock analysis
Jump to another research area for this company.